본문으로 건너뛰기
← 뒤로

The Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age.

1/5 보강
International journal of molecular sciences 📖 저널 OA 100% 2021: 8/8 OA 2022: 38/38 OA 2023: 49/49 OA 2024: 103/103 OA 2025: 453/453 OA 2026: 454/454 OA 2021~2026 2026 Vol.27(2)
Retraction 확인
출처

Nikulin MP, Lipatnikov AD, Nokel AY, Polyakova SM, Tsygankova SV, Pazynina GV, Semyanikhina AV, Ogorodnikova EV, Rogozhin DV, Rossomakhina OM, Atiakshin DA, Patsap OI, Stilidi IS, Bovin NV, Buchwalow I, Tiemann M, Shilova NV

📝 환자 설명용 한 줄

A key function of naturally occurring antibodies is to control pathologically altered cells, such as those with aberrant glycosylation.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Nikulin MP, Lipatnikov AD, et al. (2026). The Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age.. International journal of molecular sciences, 27(2). https://doi.org/10.3390/ijms27020800
MLA Nikulin MP, et al.. "The Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age.." International journal of molecular sciences, vol. 27, no. 2, 2026.
PMID 41596448 ↗

Abstract

A key function of naturally occurring antibodies is to control pathologically altered cells, such as those with aberrant glycosylation. Age-related diminution in the pool of B cells producing these immunoglobulins is linked to impaired anti-tumor immunity. In this study, the levels of antibodies against tumor-associated carbohydrate antigens (TACAs)-common in gastric cancer (GC) and other malignancies-were analyzed in 235 treatment-naïve GC patients (stages I-IV) and 76 healthy donors using a printed glycan array (PGA). We found that anti-glycan IgM levels, but not IgG, reduced with age in both patients and donors. Crucially, IgM levels against most glycans were significantly lower in the GC cohort compared with healthy donors, a trend that remained after age adjustment. Furthermore, an immunohistochemical analysis revealed that human anti-GalNAcα (Tn) antibodies-a well-characterized TACA in gastrointestinal cancers-bound to tumor cells and exhibited perinuclear and membrane staining in non-tumor surface cells within the same organ. These data support the hypothesis that gastric cancer patients have reduced levels of anti-glycan IgMs, which are responsible for the early recognition of transformed cells. This specific immunodeficiency may contribute to a permissive environment for tumor development.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기